Reduction of microbial biodiversity in GI of ME/CFS patients may increase inflammation and IDO-1 activity leading to increased TRYP catabolism and depletion. This evidence concerns the gene IDO1 and myalgic encephalomeyelitis/chronic fatigue syndrome.